SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-368441
Filing Date
2015-11-05
Accepted
2015-11-05 16:54:07
Documents
9
Period of Report
2015-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d95596d6k.htm 6-K 27311
2 EX-1.1 d95596dex11.htm EX-1.1 238284
3 EX-4.1 d95596dex41.htm EX-4.1 157018
4 EX-4.2 d95596dex42.htm EX-4.2 76372
5 EX-5.1 d95596dex51.htm EX-5.1 10746
6 EX-5.2 d95596dex52.htm EX-5.2 7798
7 EX-99.1 d95596dex991.htm EX-99.1 7318
8 GRAPHIC g95596goodwin.jpg GRAPHIC 5494
9 GRAPHIC g95596horn.jpg GRAPHIC 11467
  Complete submission text file 0001193125-15-368441.txt   549445
Mailing Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376
Business Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 151201432
SIC: 2834 Pharmaceutical Preparations